# Baxter Oncology GmbH – FDA Inspection, Jun 27, 2017

Source: https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/64eef675-4ce9-4232-82e4-ae06945fe393
Source feed: FDA_Inspections

> FDA inspection 1019700 of Baxter Oncology GmbH, June 27, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 11 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1019700
- Company Name: Baxter Oncology GmbH
- Inspection Date: 2017-06-27
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1283802 - 2025-09-26](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/d2cc3497-33d6-41da-be71-fed681081e29)
- [FDA Inspection 1249702 - 2024-08-27](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/8f606d21-cc2a-4cf4-813d-420b7e93dccc)
- [FDA Inspection 1206312 - 2023-05-03](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/49ff9f86-3d55-44a7-abeb-1a0511f483b6)
- FDA Inspection 1161093 - 2020-01-29
- FDA Inspection 1106642 - 2019-09-03

## Related Officers

- Issuing Officer
- [Issuing Officer](https://www.keypedia.com/people/dennis-cantellops-paite/3336bbb8-8520-4a8a-9085-76e7a55ca773)
- Issuing Officer

Company: https://www.keypedia.com/companies/baxter-oncology-gmbh/43dd5bdb-ca73-4678-ba1f-6ef4b5400e06

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c